Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Lantern Pharma Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 35 | 30 | −5 |
| Shares | 2.25M | 2.27M | +23.2K (+1.0%) |
| Value | $7.11M | $9.89M | +$2.78M (+39.1%) |
New holders (3)
Institutions that held Lantern Pharma Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 39,094 | $170.1K | 0.00% |
| Two Sigma Investments, LP | 16,041 | $69.8K | 0.00% |
| Simplex Trading, LLC | 1,426 | $6.00K | 0.00% |
Sold out (8)
Institutions that held Lantern Pharma Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| XTX Topco Ltd | 12,624 | $39.9K |
| Sanctuary Advisors, LLC | 10,000 | $31.6K |
| Raymond James Financial Inc | 2,730 | $8.63K |
| Curio Wealth, LLC | 2,000 | $6.32K |
| Federation des caisses Desjardins du Quebec | 800 | $2.53K |
| Parkside Financial Bank & Trust | 260 | $822 |
| Newbridge Financial Services Group, Inc. | 200 | $632 |
| FMR LLC | 74 | $234 |